Immunogenicity of glucan binding protein

Details Immunogenicity of glucan binding protein Immunogenicity of glucan binding protein

2008-01-29

2008-01-29

Swartz, Rodney P (Department: 1645)

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

Amino acid sequence disclosed in whole or in part; or...

C424S009100, C424S009200, C424S184100, C424S185100, C424S193100, C424S197110, C424S203100, C424S234100, C424S244100, C435S069100, C435S183000, C435S193000, C435S253400, C530S300000, C530S350000

Reexamination Certificate

active

07323175

ABSTRACT:
Immunogenic compositions and subunit vaccines for dental caries are described which comprise peptide subunits of glucan binding protein-B and peptide subunits of glucan binding protein-B in combination with peptide subunits of glucosyltransferase. Methods of provoking an immune response toS. mutansglucan binding protein-B or glucosyltransferase. Methods of immunizing a mammal against dental caries are also described, along with antibodies which bind particular epitopes of glucan binding protein-B or glucosyltransferase.

REFERENCES:
patent: 5019400 (1991-05-01), Gombotz et al.
patent: 5223409 (1993-06-01), Ladner et al.
patent: 5686075 (1997-11-01), Taubman et al.
patent: WO90/02809 (1990-03-01), None
patent: WO91/17271 (1991-11-01), None
patent: WO92/01047 (1992-01-01), None
patent: WO92/09690 (1992-06-01), None
patent: WO92/15679 (1992-09-01), None
patent: WO92/18619 (1992-10-01), None
patent: WO92/20791 (1992-11-01), None
patent: WO93/01288 (1993-01-01), None
Banas, et al.,Infect. Immun., 58(3):667-673 (1990).
Banas, et al.,FEMS Microbiol. Lett., 154:289-292 (1997).
Chia, et al.,Infect. Immun., 69(4):2493-2501 (2001).
Cole, et al.,Monoclonal Antibodies and Cancer Therapy, pp. 77-96 (1985).
Fuchs, et al.,Biotechnology, 9:1369-1372 (1991).
Furst, et al.,Nucleic Acids Res., 17(16):6724 (1989).
Galfre, et al.,Nature, 266(5602):550-552 (1977).
GenBank Accession No. AY046410 (2001).
GenBank Accession No. AY046411 (2001).
GenBank Accession No. AY046412 (2001).
GenBank Accession No. AY046413 (2001).
GenBank Accession No. AY046414 (2001).
Griffiths, et al.,EMBO J., 12(2):725-734 (1993).
Hamada, et al.,Microbiol. Rev., 44(2):331-384 (1980).
Hay, et al.,Hum. Antibod. Hybridomas, 3:81-85 (1992).
Higgins, et al.,CABIOS Communications, 5(2):151-153 (1989).
Hopp, et al.,Proc. Natl. Acad. Sci. USA, 78(6):3824-3828 (1981).
Huse, et al.,Science, 246:1275-1281 (1989).
Keyes, et al.,Arch. Oral Biol., 9:377-400 (1964).
Köhler, et al.,Nature, 266(5602):495-497 (1975).
Kolenbrander, P.E.,Annu. Rev. Microbiol., 54:413-437 (2000).
Lerner, E.A.,Yale J. Biol. Med., 54(5):387-402 (1981).
Loo, et al.,J. Bacteriol., 182(5):1374-1382 (2000).
Ma, et al.,Eur. J. Immunol., 24:131-138 (1994).
Mattos-Graner, et al.,J. Dent. Res., 79(6):1371-1377 (2000).
Mattos-Graner, et al.,Infect. Immun., 69(11):6931-6941 (2001).
Merrifield, R.B.,Synthesis of a Tetrapeptide, 85:2149-2154 (1963).
Navarre, et al.,Mol. Microbiol., 14(1):115-121 (1994).
Reinscheid, et al.,J. Bacteriol., 183(40:1175-1183 (2001).
Russell, R.R.B.,J. Gen. Microbiol., 112:197-201 (1979).
Sato, et al.,Infect. Immun., 65(2):668-675 (1997).
Schubert, et al.,Arch. Microbiol., 173(1):21-28 (2000).
Smith, et al.,Oral Microbiol. Immun., 5(2):57-62 (1990).
Smith, et al.,Oral Microbiol. Immun., 13(5):278-285 (1998).
Smith, et al.,Infect. Immun., 62(6):2545-2552 (1994).
Smith, et al.,Infect. Immun., 69(5):3135-3142 (2001).
Smith, et al.,Infect. Immun., 69(8):4767-4773 (2001).
Smith, et al.,Infect. Immun., 64(8):3069-3073 (1996).
Socransky, et al.,J. Clin. Microbiol., 22(2):303-305 (1985).
Svendsen, et al.,Lab. Anim. Sci., 45(1):89-93 (1995).
Tam, J.P.,Proc. Natl. Acad. Sci. USA, 85(15):5409-5413 (1988).
Taubman, et al.,J. Dent. Res., Abstract 2666, 76:347 (1997).
Van Houte, et l.,J. Dent. Res., 68(3):451-459 (1989).
U.S. non-published pending U.S. Appl. No. 09/562,328, by Andrew Lees, Martin A. Taubman and Daniel J. Smith, filed May 1, 2000.
U.S. Appl. No. 08/967,573, by Daniel J. Smith and Martin A. Taubman, filed Nov. 10, 1997.

Affiliated with

Also associated with

Rating

Immunogenicity of glucan binding protein does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Immunogenicity of glucan binding protein, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immunogenicity of glucan binding protein will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2793031